Aug 12, 2026 05:59AM
Mar 30, 2023 04:08PM
Mar 30, 2023 04:05PM
Nov 8, 2022 04:05PM
Oct 18, 2022 07:45AM
Aug 25, 2022 07:30AM
Aug 12, 2022 07:16AM Aptinyx (APTX) Phase 2b Study of NYX-2925 in Fibromyalgia Did Not Achieve Statistically Significant Separation from Placebo
Aug 12, 2022 07:15AM
Aug 4, 2022 04:05PM
Jul 15, 2022 07:47AM
May 12, 2022 04:25PM
May 12, 2022 04:05PM
Apr 27, 2022 07:47AM
Apr 7, 2022 09:20AM Pre-Open Stock Movers 04/07: (SEED) (HPQ) (CDK) Higher; (APTX) (VAPO) (RAD) Lower (more...)
Apr 7, 2022 07:01AM
Apr 7, 2022 07:00AM
Mar 23, 2022 04:11PM
Mar 23, 2022 04:05PM
Mar 9, 2022 07:47AM
Feb 28, 2022 07:25AM
Feb 9, 2022 07:00AM Aptinyx Hosts Virtual Portfolio Review Event to Showcase NYX-2925 in Chronic Pain and Provide Update on Clinical Development Programs
Jan 6, 2022 07:37AM
Dec 20, 2021 07:47AM
Dec 16, 2021 07:37AM
Nov 9, 2021 05:07PM
Nov 9, 2021 04:05PM
Oct 27, 2021 06:47AM
Oct 25, 2021 07:32AM Aptinyx to Report Third Quarter 2021 Financial Results on Tuesday, November 9, 2021
Aug 10, 2021 04:19PM
Aug 10, 2021 04:10PM
Jul 26, 2021 07:57AM
Jun 15, 2021 04:10PM
May 13, 2021 04:32PM
May 13, 2021 04:05PM
Apr 29, 2021 04:05PM Aptinyx to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
Apr 6, 2021 06:38AM
Apr 6, 2021 06:37AM
Mar 24, 2021 04:23PM
Mar 24, 2021 04:05PM
Mar 2, 2021 08:31AM
Jan 4, 2021 07:59AM
Jan 4, 2021 07:57AM Aptinyx Announces Recommencement of Phase 2 Study of NYX-2925 in Patients With Painful Diabetic Peripheral Neuropathy
Dec 16, 2020 08:30AM
Nov 12, 2020 04:05PM
Nov 12, 2020 04:03PM
Oct 29, 2020 08:37AM
Oct 26, 2020 04:01PM
Oct 22, 2020 06:17AM
Oct 21, 2020 10:59PM Aptinyx Announces Pricing of Public Offering of Common Stock
Oct 20, 2020 09:25AM

1,222,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All